Blank Audit Template in PowerPoint - PowerPoint Presentation
27
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes Information from the Annual Indian Health Service Diabetes Audit Makah couple
Blank Audit Template in PowerPoint - PowerPoint Presentation
PowerPoint PresentationDiabetes Health Status Report
Patients with Diabetes
Makah couple
Chart6
Female
Male
numbers
Health Status of Diabetic Patients
Use this spreadsheet to generate reports to illustrate patient
demographics and care outcomes tracked and reported in the Indian
Health Service Diabetes Audit. This report allows you to enter
information found either on your annual Indian Health Service
Directions:
1.Items in the yellow cells are found in the Diabetes Audit. Refer
to either your annual Indian Health Service Diabetes Audit or
generate the "cumulative audit" in the Diabetes Management
System.
2. Enter corresponding PERCENTAGES (%) into the cells for each time
frame.
3. View and print your custom report by clicking on the tabs
below.
4. Questions? Contact the Western Tribal Diabetes Program at
1-800-862-5497, attention Jen Olson.
Time 1
Time 2
Time 3
Time 4
Is this a random sample or all patients with diabetes?
Data Source
manual chart audit
Obese (BMI>95%ile)
BP control undetermined
Tobacco use not documented
Insulin
Sulfonylurea
Metformin
Acarbose
Troglitazone
Refused or Undetermined
CHRONIC ASPIRIN THERAPY
Use in pts with overt proteinuria
Use in pts with known hypertension
LIPID LOWERING AGENT USE
EXAMS - YEARLY
IMMUNIZATIONS
Proteinurea present
Proteinurea absent
Creatinine >= 2.0mg/dl
Desirable (<200 mg/dl)
Borderline (200-239 ,g/dl)
Unable to determine result
LDL <100 mg/dl
LDL 100-129 mg/dl
LDL 130-160 mg/dl
HDL <35 mg/dl
HDL 35-45 mg/dl
HDL 46-55 mg/dl
TG <150 mg/dl
TG 150-199 mg/dl
TG 200-400 mg/dl
TG >400 mg/dl
Ever performed
TUBERCULOSIS STATUS
PPD -, placed before DM dx or date unknown
PPD status unknown
Yes
No
Refused
*OPTIONS FOR STATUS::
Clinic Definitions of status (please enter your clinic's definition
for each status)
Active
Inactive
Transient
Deceased
Non-HIS
Unreviewed
0
12/31/99
0
Number of patients with diabetes included in report
0
Is this a random sample or all patients with diabetes?
0
12/31/99
&LDate last updated:&D&R&P
Patients with diabetes are at risk for activation of latent
tuberculosis (TB) infection (LBTI). There is a greater risk of
progressing to active Tuberculosis, if not treated. Patients with
diabetes should have a PPD if unknown tuberculosis status.
Time 1
time2
time3
BP control undetermined
Age is a risk factor for Type 2 Diabetes. Type 2 Diabetes was
diagnosed predominately in patients age 40 and older. Today, young
adults (30-35) are the fastest growing group of Type 2
Diabetes.
% of patients
Type of Education
% Receiving Educational Sessions
Creatinine >= 2.0mg/dl
Obese (BMI>95%ile)
LDL CHOLESTEROL OBTAINED IN PAST 12 MONTHS
LDL <100 mg/dl
LDL 100-129 mg/dl
LDL 130-160 mg/dl
Not tested
Type 1 Diabetes- Immune-mediated form of diabetes. The body
produces no insulin at all due to islet cell destruction. Type 2
Diabetes-Caused by a combination of insulin resistance and insulin
deficiency. Gestational Diabetes-Diabetes associated with
pregnancy. Pre-Diabetes (also called Impaired Glucose Tolerance
(IGT)-Pre-diabetic state marked by elevated blood sugar. People
with IGT are at high risk for progression to Type 2 diabetes.
Obesity and physical inactivity are associated with the development
of type 2 Diabetes. Adopting habits that control weight and
increasing exercise has been shown to significantly reduce the risk
of developing diabetes. Minimal weight loss of just 10-20 pounds
can improve blood glucose, blood pressure and cholesterol in
patients with type 2 Diabetes.
The target Blood Pressure (BP) for patients with diabetes is <
130/85. High blood pressure increases the risk of heart disease and
renal failure in Type 2 diabetes.
Aspirin is used as a primary and secondary treatment strategy to
prevent cardiovascular events regardless of disease status. Men and
women with diabetes have a 2-4 fold increase in risk of dying from
complications of cardiovascular disease (CVD).
ACE Inhibitors are medication prescribed to patients with diabetes
to prevent kidney damage. Treatment with ACE Inhibitors has been
shown to delay the progression from Microalbuminuria to Proteinuria
in patients with diabetes. It is commonly prescribed to patients
with hypertension as well.
Screening for foot problems, vision problems and dental problems
occur more frequently for patients with diabetes. Persons with
diabetes need their exams at least once a year.
All persons with diabetes should have a flu vaccine and pneumovax
each year. Yearly re-vaccination for flu is recommended to provide
up-to-date protection. The pneumovax vaccine is necessary at least
once and may need a booster according to physician
discretion.
Blood creatinine is a measure of renal function. Patients with
diabetes are at risk for renal disease. This test is to be
performed annually.
% of patients
Desirable (<200 mg/dl)
Borderline (200-239 ,g/dl)
Unable to determine result
HDL <35 mg/dl
HDL 35-45 mg/dl
HDL 46-55 mg/dl
TG <150 mg/dl
TG 150-199 mg/dl
TG 200-400 mg/dl
TG >400 mg/dl
Ever performed
% of patients
PPD +, INH treatment complete
PPD -, placed before DM dx or date unknown
PPD status unknown
Tuberculosis Status of Patients with Diabetes
Use in pts with overt proteinuria
Use in pts with known hypertension
Self Monitoring Blood Glucose (SMBG) is to determine the pattern of
blood glucose throughout the day. This pattern provides information
for selection and adjustments in therapy.
% of patients
Yes
No
Refused
Medical nutrition therapy and exercise are the primary treatment
strategies for type 2 Diabetes. All patients with diabetes and
their families should have diabetes self-management education every
year.
% of patients
Tobacco use not documented
Tobacco Use
Counseled - Yes
Counseled - No
Tobacco abuse is the primary preventable risk for cardiovascular
disease, which is the leading cause of death in diabetes.
Risk factors for atherosclerosis include: Total Cholesterol <200
LDL>100 HDL<40 in HDL<45 in women TG>200 All patients
with LDL >100 require medical nutrition therapy and lifestyle
modifications. Pharmacological intervention is recommended if
dietary interventions and lifestyle modifications are ineffective
in lowering LDL to less than 100. A lipid panel should be performed
annually (TC, LDL, HDL, TG).
A baseline EKG should be obtained after diagnosis of diabetes. This
should be repeated every 1-5 years as clinically indicated. For
those 40 years of age and above, or with diabetes duration of over
10 years, an EKG every 1-2 years is recommended.
no. of patients
Insulin
Sulfonylurea
Metformin
Acarbose
Troglitazone
Refused or Undetermined
Microalbuminurea present
Microalbuminurea absent
Health Status of Diabetic Patients
Demo
12/31/99
0
Number of patients with diabetes included in report
22
Is this a random sample or all patients with diabetes?
all patients with diabetes
active
manual chart audit
People with type 2 Diabetes who have Microalbuminuria are more
likely to have a heart attack or stroke. Treatment with ACE
Inhibitors slows the deterioration of kidney function in
diabetes.
% of patients
Proteinurea present
Proteinurea absent
Proteinurea not tested/unknown
Hemoglobin A1c estimates the average degree of glycemic control
over a period of time. Hemoglobin A1c should be monitored at 3-4
month intervals for those with elevated levels (HbA1C
>7.0%).
As a patient's HbA1c gets higher, the risk of complications
increases.
Over time, smoking damages the blood vessels. Coupled with too much
glucose in the blood, the effect can be devastating.
Diabetes is a disease that is disproportionately affecting the
American Indian and Alaskan Native communities. Armed with the
right information we can work together to fight and eventually
prevent this disease. First, we need to know the true facts about
diabetes in each tribe and community. This report is the picture
the numbers paint for us. This information is based on your
clinic’s tracking of diabetes in your community for a one year time
frame. It is based on information tracked in the Resource Patient
Management System (RPMS) or compiled in an annual chart review. By
looking at this information we can best target health resources,
support those in the community with diabetes and prevent diabetes
in future generations. Much of the narrative information found in
this report is taken from the 2001 "Indian Health Service Standards
of Care.
Protein appearing in the urine is an indication of kidney
disease.
Diabetes can be effectively treated and controlled. The duration of
diabetes is related to complications such as kidney disease, cardio
vascular disease and amputation. Intensive treatment can reduce the
risk of complications of diabetes.
&L&D&R&P
<15 years
15-44 years
45-64 years
Type 1
Type 2
BP control undetermined
Age is a risk factor for Type 2 Diabetes. Type 2 Diabetes was
diagnosed predominately in patients age 40 and older. Today, young
adults (30-35) are the fastest growing group of Type 2
Diabetes.
Hemoglobin A1c estimates the average degree of glycemic control
over a period of time. Hemoglobin A1c should be monitored at 3-4
month intervals for those with elevated levels (HbA1C >7.0%). As
a patients HbA1c gets higher, the risk of complications
increases.
% of patients
type of education
% Receiving Educational Sessions
HDL <35 mg/dl
HDL 35-45 mg/dl
HDL 46-55 mg/dl
Not tested
Type 1 Diabetes- Immune-mediated form of diabetes. The body
produces no insulin at all due to islet cell destruction. Type 2
Diabetes-Caused by a combination of insulin resistance and insulin
deficiency. Gestational Diabetes-Diabetes associated with
pregnancy. Impaired Glucose Tolerance (IGT)-Pre-diabetic state
marked by elevated blood sugar. People with IGT are at high risk
for progression to Type 2 diabetes.
Diabetes is not curable, but it can be effectively treated and
controlled. The duration of diabetes is related to complications
such as kidney disease, cardio vascular disease and amputation.
Intensive treatment can reduce the reisk of complications of
diabetes.
Obesity and physical inactivity are associated with the development
of type 2 Diabetes. Adopting habits that control weight and
increasing exercise has been shown to significantly reduce the risk
of developing diabetes. Minimal weight loss of just 10-20 pounds
can improve blood glucose, blood pressure and cholesterol in
patients with type 2 Diabetes.
The target Blood Pressure (BP) for patients with diabetes is <
130/80. High blood pressure increases the risk of heart disease and
renal failure in Type 2 diabetes.
Aspirin is used as a primary and secondary treatment strategy to
prevent cardiovascular events regardless of disease status. Men and
women with diabetes have a 2-4 fold increase in risk of dying from
complications of cardiovascular disease (CVD).
ACE Inhibitors are medication prescribed to patients with diabetes
to prevent kidney damage. Treatment with ACE Inhibitors has been
shown to delay the progression from Microalbuminuria to Proteinuria
in patients with diabetes. It is commonly prescribed to patients
with hypertension as well.
Screening for foot problems, vision problems and dental problems
occur more frequently for patients with diabetes. Persons with
diabetes need their exams at least once a year.
All persons with diabetes should have a flu vaccine and pneumovax
each year. Yearly re-vaccination for flu is recommended to provide
up-to-date protection. The pneumovax vaccine is necessary at least
once and may need a booster according to physician
discretion.
Blood creatinine is a measure of renal function. Patients with
diabetes are at risk for renal disease. This test is to be
performed annually.
% of patients
Total Cholesterol
Unable to determine result
Ever performed
% of patients
Performed in past 3 years
Performed in past 5 years
Ever performed
% of patients
Tuberculosis Status of Patients with Diabetes
Use in pts with overt proteinuria
Use in pts with known hypertension
Self Monitoring Blood Glucose (SMBG) is to determine the pattern of
blood glucose throughout the day. This pattern provides information
for selection and adjustments in therapy.
no. of patients
Yes
No
Refused
Medical nutrition therapy and exercise are the primary treatment
strategies for type 2 Diabetes. All patients with diabetes and
their families should have diabetes self-management education every
year.
% of patients
Tobacco use not documented
% of patients
Tobacco Use
Counseled - Yes
Counseled - No
Tobacco abuse is the primary preventable risk for cardiovascular
disease, which is the leading cause of death in diabetes. Over
time, smoking damages the blood vessels. Coupled with too much
glucose in the blood, the effect can be devastating.
Risk factors for atherosclerosis include: Total Cholesterol <200
LDL>100 HDL<40 in HDL<45 in women TG>200 All patients
with LDL >100 require medical nutrition therapy and lifestyle
modifications. Pharmacologic intervention is recommended if dietary
interventions and lifestyle modifications are ineffective in
lowering LDL to less than 100. A lipid panel should be performed
annually (TC, LDL, HDL, TG).
A baseline EKG should be obtained after diagnosis of diabetes. This
should be repeated every 1-5 years as clinically indicated. For
those 40 years of age and above, or with diabetes duration of over
10 years, an EKG every 1-2 years is recommended.
Patients with diabetes are at risk for activation of latent
tubercoulosis (TB) infection (LBTI). There is a greater risk of
progressing to active Tuberculosis, if not treated. Patients with
diabetes should have a PPD if unknown tuberculosis status.
% of patients
% of patients
Diabetes Treatment
Insulin
Sulfonylurea
Metformin
Acarbose
Troglitazone
Refused or Undetermined
Microalbuminurea present
Microalbuminurea absent
Female
Male
Protein appearing in the urine is an indication of kidney disease.
People with type 2 Diabetes who have Microalbuminuria are more
likely to have a heart attack or stroke. Treatment with ACE
Inhibitors slows the deterioration of kidney function in
diabetes.
% of patients
<15 years
15-44 years
45-64 years
Type 1
Type 2
Obese (BMI>95%ile)
BMI not calculated
Age is a risk factor for Type 2 Diabetes. Type 2 Diabetes was
diagnosed predominately in patients age 40 and older. Today, young
adults (30-35) are the fastest growing group of Type 2
Diabetes.
Hemoglobin A1c estimates the average degree of glycemic control
over a period of time. Hemoglobin A1c should be monitored at 3-4
month intervals for those with elevated levels (HbA1C >7.0%). As
a patients HbA1c gets higher, the risk of complications
increases.
% of patients
Performed in past 3 years
Performed in past 5 years
Ever performed
Type 1 Diabetes- Immune-mediated form of diabetes. The body
produces no insulin at all due to islet cell destruction. Type 2
Diabetes-Caused by a combination of insulin resistance and insulin
deficiency. Gestational Diabetes-Diabetes associated with
pregnancy. Pre-Diabetes (also called mpaired Glucose Tolerance
(IGT)-Pre-diabetic state marked by elevated blood sugar. People
with IGT are at high risk for progression to Type 2 diabetes.
Obesity and physical inactivity are associated with the development
of type 2 Diabetes. Adopting habits that control weight and
increasing exercise has been shown to significantly reduce the risk
of developing diabetes. Minimal weight loss of just 10-20 pounds
can improve blood glucose, blood pressure and cholesterol in
patients with type 2 Diabetes.
The target Blood Pressure (BP) for patients with diabetes is <
130/85. High blood pressure increases the risk of heart disease and
renal failure in Type 2 diabetes.
Aspirin is used as a primary and secondary treatment strategy to
prevent cardiovascular events regardless of disease status. Men and
women with diabetes have a 2-4 fold increase in risk of dying from
complications of cardiovascular disease (CVD).
ACE Inhibitors are medication prescribed to patients with diabetes
to prevent kidney damage. Treatment with ACE Inhibitors has been
shown to delay the progression from Microalbuminuria to Proteinuria
in patients with diabetes. It is commonly prescribed to patients
with hypertension as well.
Screening for foot problems, vision problems and dental problems
occur more frequently for patients with diabetes. Persons with
diabetes need their exams at least once a year.
All persons with diabetes should have a flu vaccine and pneumovax
each year. Yearly re-vaccination for flu is recommended to provide
up-to-date protection. The pneumovax vaccine is necessary at least
once and may need a booster according to physician
discretion.
Blood creatinine is a measure of renal function. Patients with
diabetes are at risk for renal disease. This test is to be
performed annually.
Self Monitoring Blood Glucose (SMBG) is to determine the pattern of
blood glucose throughout the day. This pattern provides information
for selection and adjustments in therapy.
% of patients
Yes
No
Refused
Medical nutrition therapy and exercise are the primary treatment
strategies for type 2 Diabetes. All patients with diabetes and
their families should have diabetes self-management education every
year.
Over time, smoking damages the blood vessels. Coupled with too much
glucose in the blood, the effect can be devastating.
Risk factors for atherosclerosis include: Total Cholesterol <200
LDL>100 HDL<40 in HDL<45 in women TG>200 All patients
with LDL >100 require medical nutrition therapy and lifestyle
modifications. Pharmacological intervention is recommended if
dietary interventions and lifestyle modifications are ineffective
in lowering LDL to less than 100. A lipid panel should be performed
annually (TC, LDL, HDL, TG).
A baseline EKG should be obtained after diagnosis of diabetes. This
should be repeated every 1-5 years as clinically indicated. For
those 40 years of age and above, or with diabetes duration of over
10 years, an EKG every 1-2 years is recommended.
Patients with diabetes are at risk for activation of latent
tuberculosis (TB) infection (LBTI). There is a greater risk of
progressing to active Tuberculosis, if not treated. Patients with
diabetes should have a PPD if unknown tuberculosis status.
Protein appearing in the urine is an indication of kidney disease.
People with type 2 Diabetes who have Microalbuminuria are more
likely to have a heart attack or stroke. Treatment with ACE
Inhibitors slows the deterioration of kidney function in
diabetes.
Diabetes is a disease that is disproportionately affecting the
American Indian and Alaskan Native communities. Armed with the
right information we can work together to fight and eventually
prevent this disease. First, we need to know the true facts about
diabetes in each tribe and community. This report is the picture
the numbers paint for us. This information is based on your
clinic’s tracking of diabetes in your community for a one year time
frame. It is based on information tracked in the Resource Patient
Management System (RPMS) or compiled in an annual chart review. By
looking at this information we can best target health resources,
support those in the community with diabetes and prevent diabetes
in future generations. Much of the narrative information found in
this report is taken from the 2001 "Indian Health Service Standards
of Care.
% of patients
PPD +, INH treatment complete
PPD -, placed before DM dx or date unknown
PPD status unknown
HDL CHOLESTEROL OBTAINED IN PAST 12 MONTHS
HDL <35 mg/dl
HDL 35-45 mg/dl
HDL 46-55 mg/dl
TG <150 mg/dl
TG 150-199 mg/dl
TG 200-400 mg/dl
TG >400 mg/dl
Desirable (<200 mg/dl)
Borderline (200-239 ,g/dl)
Unable to determine result
Creatinine >= 2.0mg/dl
Microalbuminurea present
Microalbuminurea absent
Proteinurea present
Proteinurea absent
% of patients
% of patients
Insulin
Sulfonylurea
Metformin
Acarbose
Troglitazone
Refused or Undetermined
Current Tobacco User
Tobacco use not documented
BP control undetermined
0
This information is for the following time period:
Number of patients included in this report (Denominator):
Diabetes is a disease that is disproportionately affecting the
American Indian and Alaskan Native communities. Armed with the
right information we can work together to fight and eventually
prevent this disease. First, we need to know the true facts
abou
Much of the narrative information found in this report is taken
from the 2001 "Indian Health Service Standards of Care for Patients
with Type 2 Diabetes".
Who is this report about?
Number of patients with diabetes included in report
22
0
Is this a random sample or all patients with diabetes?
0
12/31/99
12/31/99
Tobacco abuse is the primary preventable risk for cardiovascular
disease, which is the leading cause of death in diabetes.
Diabetes can be effectively treated and controlled. The duration of
diabetes is related to complications such as kidney disease, cardio
vascular disease and amputation. Intensive treatment can reduce the
risk of complications of diabetes.
&L&D&R&P
Patients with diabetes are at risk for activation of latent
tuberculosis (TB) infection (LBTI). There is a greater risk of
progressing to active Tuberculosis, if not treated. Patients with
diabetes should have a PPD if unknown tuberculosis status.
Female
Male
<15 years
15-44 years
45-64 years
Type 1
Type 2
BP control undetermined
Age is a risk factor for Type 2 Diabetes. Type 2 Diabetes was
diagnosed predominately in patients age 40 and older. Today, young
adults (30-35) are the fastest growing group of Type 2
Diabetes.
% of patients
Type of Education
% Receiving Educational Sessions
Creatinine >= 2.0mg/dl
Obese (BMI>95%ile)
LDL CHOLESTEROL OBTAINED IN PAST 12 MONTHS
LDL <100 mg/dl
LDL 100-129 mg/dl
LDL 130-160 mg/dl
Not tested
Type 1 Diabetes- Immune-mediated form of diabetes. The body
produces no insulin at all due to islet cell destruction. Type 2
Diabetes-Caused by a combination of insulin resistance and insulin
deficiency. Gestational Diabetes-Diabetes associated with
pregnancy. Pre-Diabetes (also called Impaired Glucose Tolerance
(IGT)-Pre-diabetic state marked by elevated blood sugar. People
with IGT are at high risk for progression to Type 2 diabetes.
Obesity and physical inactivity are associated with the development
of type 2 Diabetes. Adopting habits that control weight and
increasing exercise has been shown to significantly reduce the risk
of developing diabetes. Minimal weight loss of just 10-20 pounds
can improve blood glucose, blood pressure and cholesterol in
patients with type 2 Diabetes.
The target Blood Pressure (BP) for patients with diabetes is <
130/85. High blood pressure increases the risk of heart disease and
renal failure in Type 2 diabetes.
Aspirin is used as a primary and secondary treatment strategy to
prevent cardiovascular events regardless of disease status. Men and
women with diabetes have a 2-4 fold increase in risk of dying from
complications of cardiovascular disease (CVD).
ACE Inhibitors are medication prescribed to patients with diabetes
to prevent kidney damage. Treatment with ACE Inhibitors has been
shown to delay the progression from Microalbuminuria to Proteinuria
in patients with diabetes. It is commonly prescribed to patients
with hypertension as well.
Screening for foot problems, vision problems and dental problems
occur more frequently for patients with diabetes. Persons with
diabetes need their exams at least once a year.
All persons with diabetes should have a flu vaccine and pneumovax
each year. Yearly re-vaccination for flu is recommended to provide
up-to-date protection. The pneumovax vaccine is necessary at least
once and may need a booster according to physician
discretion.
Blood creatinine is a measure of renal function. Patients with
diabetes are at risk for renal disease. This test is to be
performed annually.
% of patients
Desirable (<200 mg/dl)
Borderline (200-239 ,g/dl)
Unable to determine result
HDL <35 mg/dl
HDL 35-45 mg/dl
HDL 46-55 mg/dl
TG <150 mg/dl
TG 150-199 mg/dl
TG 200-400 mg/dl
TG >400 mg/dl
Ever performed
% of patients
PPD +, INH treatment complete
PPD -, placed before DM dx or date unknown
PPD status unknown
Tuberculosis Status of Patients with Diabetes
Use in pts with overt proteinuria
Use in pts with known hypertension
Self Monitoring Blood Glucose (SMBG) is to determine the pattern of
blood glucose throughout the day. This pattern provides information
for selection and adjustments in therapy.
no. of patients
Yes
No
Refused
Medical nutrition therapy and exercise are the primary treatment
strategies for type 2 Diabetes. All patients with diabetes and
their families should have diabetes self-management education every
year.
% of patients
Tobacco use not documented
Tobacco Use
Counseled - Yes
Counseled - No
Tobacco abuse is the primary preventable risk for cardiovascular
disease, which is the leading cause of death in diabetes.
Risk factors for atherosclerosis include: Total Cholesterol <200
LDL>100 HDL<40 in HDL<45 in women TG>200
A baseline EKG should be obtained after diagnosis of diabetes. This
should be repeated every 1-5 years as clinically indicated. For
those 40 years of age and above, or with diabetes duration of over
10 years, an EKG every 1-2 years is recommended.
% of patients
% of patients
Diabetes Treatment
Insulin
Sulfonylurea
Metformin
Acarbose
Troglitazone
Refused or Undetermined
Microalbuminurea present
Microalbuminurea absent
Health Status of Diabetic Patients
0
Who is this report about?
Number of patients with diabetes included in report
0
Is this a random sample or all patients with diabetes?
0
12/31/99
12/31/99
Protein appearing in the urine is an indication of kidney
disease.
% of patients
Proteinurea present
Proteinurea absent
Proteinurea not tested/unknown
Hemoglobin A1c estimates the average degree of glycemic control
over a period of time. Hemoglobin A1c should be monitored at 3-4
month intervals for those with elevated levels (HbA1C
>7.0%).
As a patient's HbA1c gets higher, the risk of complications
increases.
Over time, smoking damages the blood vessels. Coupled with too much
glucose in the blood, the effect can be devastating.
People with type 2 Diabetes who have Microalbuminuria are more
likely to have a heart attack or stroke. Treatment with ACE
Inhibitors slows the deterioration of kidney function in
diabetes.
All patients with LDL >100 require medical nutrition therapy and
lifestyle modifications. Pharmacological intervention is
recommended if dietary interventions and lifestyle modifications
are ineffective in lowering LDL to less than 100. A lipid panel
should be performed annually (TC, LDL, HDL, TG).
Diabetes can be effectively treated and controlled. The duration of
diabetes is related to complications such as kidney disease, cardio
vascular disease and amputation. Intensive treatment can reduce the
risk of complications of diabetes.
&L&D&R&P
<15 years
15-44 years
45-64 years
Type 1
Type 2
BP control undetermined
Age is a risk factor for Type 2 Diabetes. Type 2 Diabetes was
diagnosed predominately in patients age 40 and older. Today, young
adults (30-35) are the fastest growing group of Type 2
Diabetes.
Hemoglobin A1c estimates the average degree of glycemic control
over a period of time. Hemoglobin A1c should be monitored at 3-4
month intervals for those with elevated levels (HbA1C >7.0%). As
a patients HbA1c gets higher, the risk of complications
increases.
% of patients
type of education
% Receiving Educational Sessions
HDL <35 mg/dl
HDL 35-45 mg/dl
HDL 46-55 mg/dl
Not tested
Type 1 Diabetes- Immune-mediated form of diabetes. The body
produces no insulin at all due to islet cell destruction. Type 2
Diabetes-Caused by a combination of insulin resistance and insulin
deficiency. Gestational Diabetes-Diabetes associated with
pregnancy. Impaired Glucose Tolerance (IGT)-Pre-diabetic state
marked by elevated blood sugar. People with IGT are at high risk
for progression to Type 2 diabetes.
Diabetes is not curable, but it can be effectively treated and
controlled. The duration of diabetes is related to complications
such as kidney disease, cardio vascular disease and amputation.
Intensive treatment can reduce the reisk of complications of
diabetes.
Obesity and physical inactivity are associated with the development
of type 2 Diabetes. Adopting habits that control weight and
increasing exercise has been shown to significantly reduce the risk
of developing diabetes. Minimal weight loss of just 10-20 pounds
can improve blood glucose, blood pressure and cholesterol in
patients with type 2 Diabetes.
The target Blood Pressure (BP) for patients with diabetes is <
130/80. High blood pressure increases the risk of heart disease and
renal failure in Type 2 diabetes.
Aspirin is used as a primary and secondary treatment strategy to
prevent cardiovascular events regardless of disease status. Men and
women with diabetes have a 2-4 fold increase in risk of dying from
complications of cardiovascular disease (CVD).
ACE Inhibitors are medication prescribed to patients with diabetes
to prevent kidney damage. Treatment with ACE Inhibitors has been
shown to delay the progression from Microalbuminuria to Proteinuria
in patients with diabetes. It is commonly prescribed to patients
with hypertension as well.
Screening for foot problems, vision problems and dental problems
occur more frequently for patients with diabetes. Persons with
diabetes need their exams at least once a year.
All persons with diabetes should have a flu vaccine and pneumovax
each year. Yearly re-vaccination for flu is recommended to provide
up-to-date protection. The pneumovax vaccine is necessary at least
once and may need a booster according to physician
discretion.
Blood creatinine is a measure of renal function. Patients with
diabetes are at risk for renal disease. This test is to be
performed annually.
% of patients
Total Cholesterol
Unable to determine result
Ever performed
% of patients
Performed in past 3 years
Performed in past 5 years
Ever performed
% of patients
Tuberculosis Status of Patients with Diabetes
Use in pts with overt proteinuria
Use in pts with known hypertension
Self Monitoring Blood Glucose (SMBG) is to determine the pattern of
blood glucose throughout the day. This pattern provides information
for selection and adjustments in therapy.
no. of patients
Yes
No
Refused
Medical nutrition therapy and exercise are the primary treatment
strategies for type 2 Diabetes. All patients with diabetes and
their families should have diabetes self-management education every
year.
% of patients
Tobacco use not documented
% of patients
Tobacco Use
Counseled - Yes
Counseled - No
Tobacco abuse is the primary preventable risk for cardiovascular
disease, which is the leading cause of death in diabetes. Over
time, smoking damages the blood vessels. Coupled with too much
glucose in the blood, the effect can be devastating.
Risk factors for atherosclerosis include: Total Cholesterol <200
LDL>100 HDL<40 in HDL<45 in women TG>200 All patients
with LDL >100 require medical nutrition therapy and lifestyle
modifications. Pharmacologic intervention is recommended if dietary
interventions and lifestyle modifications are ineffective in
lowering LDL to less than 100. A lipid panel should be performed
annually (TC, LDL, HDL, TG).
A baseline EKG should be obtained after diagnosis of diabetes. This
should be repeated every 1-5 years as clinically indicated. For
those 40 years of age and above, or with diabetes duration of over
10 years, an EKG every 1-2 years is recommended.
Patients with diabetes are at risk for activation of latent
tubercoulosis (TB) infection (LBTI). There is a greater risk of
progressing to active Tuberculosis, if not treated. Patients with
diabetes should have a PPD if unknown tuberculosis status.
no. of patients
Insulin
Sulfonylurea
Metformin
Acarbose
Troglitazone
Refused or Undetermined
Proteinurea present
Proteinurea absent
<15 years
15-44 years
45-64 years
65 years and older
Protein appearing in the urine is an indication of kidney disease.
People with type 2 Diabetes who have Microalbuminuria are more
likely to have a heart attack or stroke. Treatment with ACE
Inhibitors slows the deterioration of kidney function in
diabetes.
Patients with diabetes are at risk for activation of latent
tuberculosis (TB) infection (LBTI). There is a greater risk of
progressing to active Tuberculosis, if not treated. Patients with
diabetes should have a PPD if unknown tuberculosis status.
Gender Distribution of Patients with Diabetes Included in
Report
Female
Male
Type 1
Type 2
BP control undetermined
Hemoglobin A1c estimates the average degree of glycemic control
over a period of time. Hemoglobin A1c should be monitored at 3-4
month intervals for those with elevated levels (HbA1C >7.0%). As
a patients HbA1c gets higher, the risk of complications
increases.
% of patients
type of education
% Receiving Educational Sessions
Creatinine >= 2.0mg/dl
Obese (BMI>95%ile)
LDL CHOLESTEROL OBTAINED IN PAST 12 MONTHS
LDL <100 mg/dl
LDL 100-129 mg/dl
LDL 130-160 mg/dl
Not tested
Type 1 Diabetes- Immune-mediated form of diabetes. The body
produces no insulin at all due to islet cell destruction. Type 2
Diabetes-Caused by a combination of insulin resistance and insulin
deficiency. Gestational Diabetes-Diabetes associated with
pregnancy. Pre-diabetes (also called Impaired Glucose Tolerance
(IGT)-Pre-diabetic state marked by elevated blood sugar. People
with Pre-diabetes are at high risk for progression to Type 2
diabetes.
Diabetes is not curable, but it can be effectively treated and
controlled. The duration of diabetes is related to complications
such as kidney disease, cardio vascular disease and amputation.
Intensive treatment and lifestlye interventions can reduce the risk
of complications of diabetes.
Obesity and physical inactivity are associated with the development
of type 2 Diabetes. Adopting habits that control weight and
increasing exercise has been shown to significantly reduce the risk
of developing diabetes. Minimal weight loss of just 10-20 pounds
can improve blood glucose, blood pressure and cholesterol in
patients with type 2 diabetes.
The target Blood Pressure (BP) for patients with diabetes is <
130/85. High blood pressure increases the risk of heart disease and
renal failure in Type 2 diabetes.
Aspirin is used as a primary and secondary treatment strategy to
prevent cardiovascular events regardless of disease status. Men and
women with diabetes have a 2-4 fold increase in risk of dying from
complications of cardiovascular disease (CVD). Unless there are
reasons otherwise , all patients with diabetes should be on aspirin
therapy.
ACE Inhibitors are medication prescribed to patients with diabetes
to prevent kidney damage. Treatment with ACE Inhibitors has been
shown to delay the progression from Microalbuminuria to Proteinuria
in patients with diabetes. It is commonly prescribed to patients
with hypertension as well.
Screening for foot problems, vision problems and dental problems
occur more frequently for patients with diabetes. Persons with
diabetes need their exams at least once a year.
All persons with diabetes should have a flu vaccine and pneumovax
each year. Yearly re-vaccination for flu is recommended to provide
up-to-date protection. The pneumovax vaccine is necessary at least
once and may need a booster according to physician
discretion.
Blood creatinine is a measure of renal function. Patients with
diabetes are at risk for renal disease. This test is to be
performed annually.
% of patients
Desirable (<200 mg/dl)
Borderline (200-239 ,g/dl)
Unable to determine result
HDL <35 mg/dl
HDL 35-45 mg/dl
HDL 46-55 mg/dl
TG <150 mg/dl
TG 150-199 mg/dl
TG 200-400 mg/dl
TG >400 mg/dl
Ever performed
% of patients
PPD +, INH treatment complete
PPD -, placed before DM dx or date unknown
PPD status unknown
Tuberculosis Status of Patients with Diabetes
Use in pts with overt proteinuria
Use in pts with known hypertension
Self Monitoring Blood Glucose (SMBG) is to determine the pattern of
blood glucose throughout the day. This pattern provides information
for selection and adjustments in therapy.
% of patients
Yes
No
Refused
Medical nutrition therapy and exercise are the primary treatment
strategies for type 2 Diabetes. All patients with diabetes and
their families should have diabetes self-management education every
year.
% of patients
Tobacco use not documented
Tobacco Use
Counseled - Yes
Counseled - No
Over time, smoking damages the blood vessels. Coupled with too much
glucose in the blood, the effect can be devastating.
Risk factors for atherosclerosis include: Total Cholesterol <200
LDL>100 HDL<40 in HDL<45 in women TG>200 All patients
with LDL >100 require medical nutrition therapy and lifestyle
modifications. Pharmacological intervention is recommended if
dietary interventions and lifestyle modifications are ineffective
in lowering LDL to less than 100. A lipid panel should be performed
annually (TC, LDL, HDL, TG).
A baseline EKG should be obtained after diagnosis of diabetes. This
should be repeated every 1-5 years as clinically indicated. For
those 40 years of age and above, or with diabetes duration of over
10 years, an EKG every 1-2 years is recommended.
% of patients
% of patients
Diabetes Treatment
Insulin
Sulfonylurea
Metformin
Acarbose
Troglitazone
Refused or Undetermined
Microalbuminurea present
Microalbuminurea absent
Diabetes Data Report - Comparison
12/31/99
12/31/99
12/31/99
12/31/99
Denominator:
0
0
0
0
The following report tracks diabetes over four time periods. By
viewing the diabetes related information over time we can track
improvements in patient care and disease management. As you look at
these graphs think about factors that may be contributing
Who is this report about?
Status of Patients included in report
12/31/99
12/31/99
Protein appearing in the urine is an indication of kidney disease.
People with type 2 Diabetes who have Microalbuminuria are more
likely to have a heart attack or stroke. Treatment with ACE
Inhibitors slows the deterioration of kidney function in
diabetes.
% of patients
Proteinurea present
Proteinurea absent
Proteinurea not tested/unknown
Diabetes is a disease that is disproportionately affecting the
American Indian and Alaskan Native communities. Armed with the
right information we can work together to fight and eventually
prevent this disease. First, we need to know the true facts about
diabetes in each tribe and community. This report is the picture
the numbers paint for us. This information is based on your
clinic’s tracking of diabetes in your community for a one year time
frame. It is based on information tracked in the Resource Patient
Management System (RPMS) or compiled in an annual chart review. By
looking at this information we can best target health resources,
support those in the community with diabetes and prevent diabetes
in future generations. Much of the narrative information found in
this report is taken from the 2001 "Indian Health Service Standards
of Care.
Tobacco abuse is the primary preventable risk for cardiovascular
disease, which is the leading cause of death in diabetes.
Diabetes can be effectively treated and controlled. The duration of
diabetes is related to complications such as kidney disease, cardio
vascular disease and amputation. Intensive treatment can reduce the
risk of complications of diabetes.
&LDRAFT &D&R&P
%
Female
Male
<15 years
15-44 years
45-64 years
Type 1
Type 2
BP control undetermined
Tobacco use not documented
Diet and Exercise Alone or Undocumented
Insulin
Sulfonylurea
Metformin
Acarbose
Troglitazone
Refused or Undetermined
%
%
%
Unable to determine result
TG <150 mg/dl
TG 150-199 mg/dl
TG 200-400 mg/dl
TG >400 mg/dl
Ever performed
PPD -, placed before DM dx or date unknown
PPD status unknown
Less than 10 years
10 years or more
Diagnosis date not recorded
Obese (BMI>95%ile)
Age is a risk factor for Type 2 Diabetes.
Type 2 Diabetes was diagnosed predominately in patients age 40 and
older.
Today, young adults (30-35) are the fastest growing group of Type 2
Diabetes.
Chart5
numbers
Health Status of Diabetic Patients
Use this spreadsheet to generate reports to illustrate patient
demographics and care outcomes tracked and reported in the Indian
Health Service Diabetes Audit. This report allows you to enter
information found either on your annual Indian Health Service
Directions:
1.Items in the yellow cells are found in the Diabetes Audit. Refer
to either your annual Indian Health Service Diabetes Audit or
generate the "cumulative audit" in the Diabetes Management
System.
2. Enter corresponding PERCENTAGES (%) into the cells for each time
frame.
3. View and print your custom report by clicking on the tabs
below.
4. Questions? Contact the Western Tribal Diabetes Program at
1-800-862-5497, attention Jen Olson.
Time 1
Time 2
Time 3
Time 4
Is this a random sample or all patients with diabetes?
Data Source
manual chart audit
Obese (BMI>95%ile)
BP control undetermined
Tobacco use not documented
Insulin
Sulfonylurea
Metformin
Acarbose
Troglitazone
Refused or Undetermined
CHRONIC ASPIRIN THERAPY
Use in pts with overt proteinuria
Use in pts with known hypertension
LIPID LOWERING AGENT USE
EXAMS - YEARLY
IMMUNIZATIONS
Proteinurea present
Proteinurea absent
Creatinine >= 2.0mg/dl
Desirable (<200 mg/dl)
Borderline (200-239 ,g/dl)
Unable to determine result
LDL <100 mg/dl
LDL 100-129 mg/dl
LDL 130-160 mg/dl
HDL <35 mg/dl
HDL 35-45 mg/dl
HDL 46-55 mg/dl
TG <150 mg/dl
TG 150-199 mg/dl
TG 200-400 mg/dl
TG >400 mg/dl
Ever performed
TUBERCULOSIS STATUS
PPD -, placed before DM dx or date unknown
PPD status unknown
Yes
No
Refused
*OPTIONS FOR STATUS::
Clinic Definitions of status (please enter your clinic's definition
for each status)
Active
Inactive
Transient
Deceased
Non-HIS
Unreviewed
0
12/31/99
0
Number of patients with diabetes included in report
0
Is this a random sample or all patients with diabetes?
0
12/31/99
&LDate last updated:&D&R&P
Patients with diabetes are at risk for activation of latent
tuberculosis (TB) infection (LBTI). There is a greater risk of
progressing to active Tuberculosis, if not treated. Patients with
diabetes should have a PPD if unknown tuberculosis status.
Time 1
time2
time3
BP control undetermined
Age is a risk factor for Type 2 Diabetes. Type 2 Diabetes was
diagnosed predominately in patients age 40 and older. Today, young
adults (30-35) are the fastest growing group of Type 2
Diabetes.
% of patients
Type of Education
% Receiving Educational Sessions
Creatinine >= 2.0mg/dl
Obese (BMI>95%ile)
LDL CHOLESTEROL OBTAINED IN PAST 12 MONTHS
LDL <100 mg/dl
LDL 100-129 mg/dl
LDL 130-160 mg/dl
Not tested
Type 1 Diabetes- Immune-mediated form of diabetes. The body
produces no insulin at all due to islet cell destruction. Type 2
Diabetes-Caused by a combination of insulin resistance and insulin
deficiency. Gestational Diabetes-Diabetes associated with
pregnancy. Pre-Diabetes (also called Impaired Glucose Tolerance
(IGT)-Pre-diabetic state marked by elevated blood sugar. People
with IGT are at high risk for progression to Type 2 diabetes.
Obesity and physical inactivity are associated with the development
of type 2 Diabetes. Adopting habits that control weight and
increasing exercise has been shown to significantly reduce the risk
of developing diabetes. Minimal weight loss of just 10-20 pounds
can improve blood glucose, blood pressure and cholesterol in
patients with type 2 Diabetes.
The target Blood Pressure (BP) for patients with diabetes is <
130/85. High blood pressure increases the risk of heart disease and
renal failure in Type 2 diabetes.
Aspirin is used as a primary and secondary treatment strategy to
prevent cardiovascular events regardless of disease status. Men and
women with diabetes have a 2-4 fold increase in risk of dying from
complications of cardiovascular disease (CVD).
ACE Inhibitors are medication prescribed to patients with diabetes
to prevent kidney damage. Treatment with ACE Inhibitors has been
shown to delay the progression from Microalbuminuria to Proteinuria
in patients with diabetes. It is commonly prescribed to patients
with hypertension as well.
Screening for foot problems, vision problems and dental problems
occur more frequently for patients with diabetes. Persons with
diabetes need their exams at least once a year.
All persons with diabetes should have a flu vaccine and pneumovax
each year. Yearly re-vaccination for flu is recommended to provide
up-to-date protection. The pneumovax vaccine is necessary at least
once and may need a booster according to physician
discretion.
Blood creatinine is a measure of renal function. Patients with
diabetes are at risk for renal disease. This test is to be
performed annually.
% of patients
Desirable (<200 mg/dl)
Borderline (200-239 ,g/dl)
Unable to determine result
HDL <35 mg/dl
HDL 35-45 mg/dl
HDL 46-55 mg/dl
TG <150 mg/dl
TG 150-199 mg/dl
TG 200-400 mg/dl
TG >400 mg/dl
Ever performed
% of patients
PPD +, INH treatment complete
PPD -, placed before DM dx or date unknown
PPD status unknown
Tuberculosis Status of Patients with Diabetes
Use in pts with overt proteinuria
Use in pts with known hypertension
Self Monitoring Blood Glucose (SMBG) is to determine the pattern of
blood glucose throughout the day. This pattern provides information
for selection and adjustments in therapy.
% of patients
Yes
No
Refused
Medical nutrition therapy and exercise are the primary treatment
strategies for type 2 Diabetes. All patients with diabetes and
their families should have diabetes self-management education every
year.
% of patients
Tobacco use not documented
Tobacco Use
Counseled - Yes
Counseled - No
Tobacco abuse is the primary preventable risk for cardiovascular
disease, which is the leading cause of death in diabetes.
Risk factors for atherosclerosis include: Total Cholesterol <200
LDL>100 HDL<40 in HDL<45 in women TG>200 All patients
with LDL >100 require medical nutrition therapy and lifestyle
modifications. Pharmacological intervention is recommended if
dietary interventions and lifestyle modifications are ineffective
in lowering LDL to less than 100. A lipid panel should be performed
annually (TC, LDL, HDL, TG).
A baseline EKG should be obtained after diagnosis of diabetes. This
should be repeated every 1-5 years as clinically indicated. For
those 40 years of age and above, or with diabetes duration of over
10 years, an EKG every 1-2 years is recommended.
no. of patients
Insulin
Sulfonylurea
Metformin
Acarbose
Troglitazone
Refused or Undetermined
Microalbuminurea present
Microalbuminurea absent
Health Status of Diabetic Patients
Demo
12/31/99
0
Number of patients with diabetes included in report
22
Is this a random sample or all patients with diabetes?
all patients with diabetes
active
manual chart audit
People with type 2 Diabetes who have Microalbuminuria are more
likely to have a heart attack or stroke. Treatment with ACE
Inhibitors slows the deterioration of kidney function in
diabetes.
% of patients
Proteinurea present
Proteinurea absent
Proteinurea not tested/unknown
Hemoglobin A1c estimates the average degree of glycemic control
over a period of time. Hemoglobin A1c should be monitored at 3-4
month intervals for those with elevated levels (HbA1C
>7.0%).
As a patient's HbA1c gets higher, the risk of complications
increases.
Over time, smoking damages the blood vessels. Coupled with too much
glucose in the blood, the effect can be devastating.
Diabetes is a disease that is disproportionately affecting the
American Indian and Alaskan Native communities. Armed with the
right information we can work together to fight and eventually
prevent this disease. First, we need to know the true facts about
diabetes in each tribe and community. This report is the picture
the numbers paint for us. This information is based on your
clinic’s tracking of diabetes in your community for a one year time
frame. It is based on information tracked in the Resource Patient
Management System (RPMS) or compiled in an annual chart review. By
looking at this information we can best target health resources,
support those in the community with diabetes and prevent diabetes
in future generations. Much of the narrative information found in
this report is taken from the 2001 "Indian Health Service Standards
of Care.
Protein appearing in the urine is an indication of kidney
disease.
Diabetes can be effectively treated and controlled. The duration of
diabetes is related to complications such as kidney disease, cardio
vascular disease and amputation. Intensive treatment can reduce the
risk of complications of diabetes.
&L&D&R&P
<15 years
15-44 years
45-64 years
Type 1
Type 2
BP control undetermined
Age is a risk factor for Type 2 Diabetes. Type 2 Diabetes was
diagnosed predominately in patients age 40 and older. Today, young
adults (30-35) are the fastest growing group of Type 2
Diabetes.
Hemoglobin A1c estimates the average degree of glycemic control
over a period of time. Hemoglobin A1c should be monitored at 3-4
month intervals for those with elevated levels (HbA1C >7.0%). As
a patients HbA1c gets higher, the risk of complications
increases.
% of patients
type of education
% Receiving Educational Sessions
HDL <35 mg/dl
HDL 35-45 mg/dl
HDL 46-55 mg/dl
Not tested
Type 1 Diabetes- Immune-mediated form of diabetes. The body
produces no insulin at all due to islet cell destruction. Type 2
Diabetes-Caused by a combination of insulin resistance and insulin
deficiency. Gestational Diabetes-Diabetes associated with
pregnancy. Impaired Glucose Tolerance (IGT)-Pre-diabetic state
marked by elevated blood sugar. People with IGT are at high risk
for progression to Type 2 diabetes.
Diabetes is not curable, but it can be effectively treated and
controlled. The duration of diabetes is related to complications
such as kidney disease, cardio vascular disease and amputation.
Intensive treatment can reduce the reisk of complications of
diabetes.
Obesity and physical inactivity are associated with the development
of type 2 Diabetes. Adopting habits that control weight and
increasing exercise has been shown to significantly reduce the risk
of developing diabetes. Minimal weight loss of just 10-20 pounds
can improve blood glucose, blood pressure and cholesterol in
patients with type 2 Diabetes.
The target Blood Pressure (BP) for patients with diabetes is <
130/80. High blood pressure increases the risk of heart disease and
renal failure in Type 2 diabetes.
Aspirin is used as a primary and secondary treatment strategy to
prevent cardiovascular events regardless of disease status. Men and
women with diabetes have a 2-4 fold increase in risk of dying from
complications of cardiovascular disease (CVD).
ACE Inhibitors are medication prescribed to patients with diabetes
to prevent kidney damage. Treatment with ACE Inhibitors has been
shown to delay the progression from Microalbuminuria to Proteinuria
in patients with diabetes. It is commonly prescribed to patients
with hypertension as well.
Screening for foot problems, vision problems and dental problems
occur more frequently for patients with diabetes. Persons with
diabetes need their exams at least once a year.
All persons with diabetes should have a flu vaccine and pneumovax
each year. Yearly re-vaccination for flu is recommended to provide
up-to-date protection. The pneumovax vaccine is necessary at least
once and may need a booster according to physician
discretion.
Blood creatinine is a measure of renal function. Patients with
diabetes are at risk for renal disease. This test is to be
performed annually.
% of patients
Total Cholesterol
Unable to determine result
Ever performed
% of patients
Performed in past 3 years
Performed in past 5 years
Ever performed
% of patients
Tuberculosis Status of Patients with Diabetes
Use in pts with overt proteinuria
Use in pts with known hypertension
Self Monitoring Blood Glucose (SMBG) is to determine the pattern of
blood glucose throughout the day. This pattern provides information
for selection and adjustments in therapy.
no. of patients
Yes
No
Refused
Medical nutrition therapy and exercise are the primary treatment
strategies for type 2 Diabetes. All patients with diabetes and
their families should have diabetes self-management education every
year.
% of patients
Tobacco use not documented
% of patients
Tobacco Use
Counseled - Yes
Counseled - No
Tobacco abuse is the primary preventable risk for cardiovascular
disease, which is the leading cause of death in diabetes. Over
time, smoking damages the blood vessels. Coupled with too much
glucose in the blood, the effect can be devastating.
Risk factors for atherosclerosis include: Total Cholesterol <200
LDL>100 HDL<40 in HDL<45 in women TG>200 All patients
with LDL >100 require medical nutrition therapy and lifestyle
modifications. Pharmacologic intervention is recommended if dietary
interventions and lifestyle modifications are ineffective in
lowering LDL to less than 100. A lipid panel should be performed
annually (TC, LDL, HDL, TG).
A baseline EKG should be obtained after diagnosis of diabetes. This
should be repeated every 1-5 years as clinically indicated. For
those 40 years of age and above, or with diabetes duration of over
10 years, an EKG every 1-2 years is recommended.
Patients with diabetes are at risk for activation of latent
tubercoulosis (TB) infection (LBTI). There is a greater risk of
progressing to active Tuberculosis, if not treated. Patients with
diabetes should have a PPD if unknown tuberculosis status.
% of patients
% of patients
Diabetes Treatment
Insulin
Sulfonylurea
Metformin
Acarbose
Troglitazone
Refused or Undetermined
Microalbuminurea present
Microalbuminurea absent
Female
Male
Protein appearing in the urine is an indication of kidney disease.
People with type 2 Diabetes who have Microalbuminuria are more
likely to have a heart attack or stroke. Treatment with ACE
Inhibitors slows the deterioration of kidney function in
diabetes.
% of patients
<15 years
15-44 years
45-64 years
Type 1
Type 2
Obese (BMI>95%ile)
BMI not calculated
Age is a risk factor for Type 2 Diabetes. Type 2 Diabetes was
diagnosed predominately in patients age 40 and older. Today, young
adults (30-35) are the fastest growing group of Type 2
Diabetes.
Hemoglobin A1c estimates the average degree of glycemic control
over a period of time. Hemoglobin A1c should be monitored at 3-4
month intervals for those with elevated levels (HbA1C >7.0%). As
a patients HbA1c gets higher, the risk of complications
increases.
% of patients
Performed in past 3 years
Performed in past 5 years
Ever performed
Type 1 Diabetes- Immune-mediated form of diabetes. The body
produces no insulin at all due to islet cell destruction. Type 2
Diabetes-Caused by a combination of insulin resistance and insulin
deficiency. Gestational Diabetes-Diabetes associated with
pregnancy. Pre-Diabetes (also called mpaired Glucose Tolerance
(IGT)-Pre-diabetic state marked by elevated blood sugar. People
with IGT are at high risk for progression to Type 2 diabetes.
Obesity and physical inactivity are associated with the development
of type 2 Diabetes. Adopting habits that control weight and
increasing exercise has been shown to significantly reduce the risk
of developing diabetes. Minimal weight loss of just 10-20 pounds
can improve blood glucose, blood pressure and cholesterol in
patients with type 2 Diabetes.
The target Blood Pressure (BP) for patients with diabetes is <
130/85. High blood pressure increases the risk of heart disease and
renal failure in Type 2 diabetes.
Aspirin is used as a primary and secondary treatment strategy to
prevent cardiovascular events regardless of disease status. Men and
women with diabetes have a 2-4 fold increase in risk of dying from
complications of cardiovascular disease (CVD).
ACE Inhibitors are medication prescribed to patients with diabetes
to prevent kidney damage. Treatment with ACE Inhibitors has been
shown to delay the progression from Microalbuminuria to Proteinuria
in patients with diabetes. It is commonly prescribed to patients
with hypertension as well.
Screening for foot problems, vision problems and dental problems
occur more frequently for patients with diabetes. Persons with
diabetes need their exams at least once a year.
All persons with diabetes should have a flu vaccine and pneumovax
each year. Yearly re-vaccination for flu is recommended to provide
up-to-date protection. The pneumovax vaccine is necessary at least
once and may need a booster according to physician
discretion.
Blood creatinine is a measure of renal function. Patients with
diabetes are at risk for renal disease. This test is to be
performed annually.
Self Monitoring Blood Glucose (SMBG) is to determine the pattern of
blood glucose throughout the day. This pattern provides information
for selection and adjustments in therapy.
% of patients
Yes
No
Refused
Medical nutrition therapy and exercise are the primary treatment
strategies for type 2 Diabetes. All patients with diabetes and
their families should have diabetes self-management education every
year.
Over time, smoking damages the blood vessels. Coupled with too much
glucose in the blood, the effect can be devastating.
Risk factors for atherosclerosis include: Total Cholesterol <200
LDL>100 HDL<40 in HDL<45 in women TG>200 All patients
with LDL >100 require medical nutrition therapy and lifestyle
modifications. Pharmacological intervention is recommended if
dietary interventions and lifestyle modifications are ineffective
in lowering LDL to less than 100. A lipid panel should be performed
annually (TC, LDL, HDL, TG).
A baseline EKG should be obtained after diagnosis of diabetes. This
should be repeated every 1-5 years as clinically indicated. For
those 40 years of age and above, or with diabetes duration of over
10 years, an EKG every 1-2 years is recommended.
Patients with diabetes are at risk for activation of latent
tuberculosis (TB) infection (LBTI). There is a greater risk of
progressing to active Tuberculosis, if not treated. Patients with
diabetes should have a PPD if unknown tuberculosis status.
Protein appearing in the urine is an indication of kidney disease.
People with type 2 Diabetes who have Microalbuminuria are more
likely to have a heart attack or stroke. Treatment with ACE
Inhibitors slows the deterioration of kidney function in
diabetes.
Diabetes is a disease that is disproportionately affecting the
American Indian and Alaskan Native communities. Armed with the
right information we can work together to fight and eventually
prevent this disease. First, we need to know the true facts about
diabetes in each tribe and community. This report is the picture
the numbers paint for us. This information is based on your
clinic’s tracking of diabetes in your community for a one year time
frame. It is based on information tracked in the Resource Patient
Management System (RPMS) or compiled in an annual chart review. By
looking at this information we can best target health resources,
support those in the community with diabetes and prevent diabetes
in future generations. Much of the narrative information found in
this report is taken from the 2001 "Indian Health Service Standards
of Care.
% of patients
PPD +, INH treatment complete
PPD -, placed before DM dx or date unknown
PPD status unknown
HDL CHOLESTEROL OBTAINED IN PAST 12 MONTHS
HDL <35 mg/dl
HDL 35-45 mg/dl
HDL 46-55 mg/dl
TG <150 mg/dl
TG 150-199 mg/dl
TG 200-400 mg/dl
TG >400 mg/dl
Desirable (<200 mg/dl)
Borderline (200-239 ,g/dl)
Unable to determine result
Creatinine >= 2.0mg/dl
Microalbuminurea present
Microalbuminurea absent
Proteinurea present
Proteinurea absent
% of patients
% of patients
Insulin
Sulfonylurea
Metformin
Acarbose
Troglitazone
Refused or Undetermined
Current Tobacco User
Tobacco use not documented
BP control undetermined
0
This information is for the following time period:
Number of patients included in this report (Denominator):
Diabetes is a disease that is disproportionately affecting the
American Indian and Alaskan Native communities. Armed with the
right information we can work together to fight and eventually
prevent this disease. First, we need to know the true facts
abou
Much of the narrative information found in this report is taken
from the 2001 "Indian Health Service Standards of Care for Patients
with Type 2 Diabetes".
Who is this report about?
Number of patients with diabetes included in report
22
0
Is this a random sample or all patients with diabetes?
0
12/31/99
12/31/99
Tobacco abuse is the primary preventable risk for cardiovascular
disease, which is the leading cause of death in diabetes.
Diabetes can be effectively treated and controlled. The duration of
diabetes is related to complications such as kidney disease, cardio
vascular disease and amputation. Intensive treatment can reduce the
risk of complications of diabetes.
&L&D&R&P
Patients with diabetes are at risk for activation of latent
tuberculosis (TB) infection (LBTI). There is a greater risk of
progressing to active Tuberculosis, if not treated. Patients with
diabetes should have a PPD if unknown tuberculosis status.
Female
Male
<15 years
15-44 years
45-64 years
Type 1
Type 2
BP control undetermined
Age is a risk factor for Type 2 Diabetes. Type 2 Diabetes was
diagnosed predominately in patients age 40 and older. Today, young
adults (30-35) are the fastest growing group of Type 2
Diabetes.
% of patients
Type of Education
% Receiving Educational Sessions
Creatinine >= 2.0mg/dl
Obese (BMI>95%ile)
LDL CHOLESTEROL OBTAINED IN PAST 12 MONTHS
LDL <100 mg/dl
LDL 100-129 mg/dl
LDL 130-160 mg/dl
Not tested
Type 1 Diabetes- Immune-mediated form of diabetes. The body
produces no insulin at all due to islet cell destruction. Type 2
Diabetes-Caused by a combination of insulin resistance and insulin
deficiency. Gestational Diabetes-Diabetes associated with
pregnancy. Pre-Diabetes (also called Impaired Glucose Tolerance
(IGT)-Pre-diabetic state marked by elevated blood sugar. People
with IGT are at high risk for progression to Type 2 diabetes.
Obesity and physical inactivity are associated with the development
of type 2 Diabetes. Adopting habits that control weight and
increasing exercise has been shown to significantly reduce the risk
of developing diabetes. Minimal weight loss of just 10-20 pounds
can improve blood glucose, blood pressure and cholesterol in
patients with type 2 Diabetes.
The target Blood Pressure (BP) for patients with diabetes is <
130/85. High blood pressure increases the risk of heart disease and
renal failure in Type 2 diabetes.
Aspirin is used as a primary and secondary treatment strategy to
prevent cardiovascular events regardless of disease status. Men and
women with diabetes have a 2-4 fold increase in risk of dying from
complications of cardiovascular disease (CVD).
ACE Inhibitors are medication prescribed to patients with diabetes
to prevent kidney damage. Treatment with ACE Inhibitors has been
shown to delay the progression from Microalbuminuria to Proteinuria
in patients with diabetes. It is commonly prescribed to patients
with hypertension as well.
Screening for foot problems, vision problems and dental problems
occur more frequently for patients with diabetes. Persons with
diabetes need their exams at least once a year.
All persons with diabetes should have a flu vaccine and pneumovax
each year. Yearly re-vaccination for flu is recommended to provide
up-to-date protection. The pneumovax vaccine is necessary at least
once and may need a booster according to physician
discretion.
Blood creatinine is a measure of renal function. Patients with
diabetes are at risk for renal disease. This test is to be
performed annually.
% of patients
Desirable (<200 mg/dl)
Borderline (200-239 ,g/dl)
Unable to determine result
HDL <35 mg/dl
HDL 35-45 mg/dl
HDL 46-55 mg/dl
TG <150 mg/dl
TG 150-199 mg/dl
TG 200-400 mg/dl
TG >400 mg/dl
Ever performed
% of patients
PPD +, INH treatment complete
PPD -, placed before DM dx or date unknown
PPD status unknown
Tuberculosis Status of Patients with Diabetes
Use in pts with overt proteinuria
Use in pts with known hypertension
Self Monitoring Blood Glucose (SMBG) is to determine the pattern of
blood glucose throughout the day. This pattern provides information
for selection and adjustments in therapy.
no. of patients
Yes
No
Refused
Medical nutrition therapy and exercise are the primary treatment
strategies for type 2 Diabetes. All patients with diabetes and
their families should have diabetes self-management education every
year.
% of patients
Tobacco use not documented
Tobacco Use
Counseled - Yes
Counseled - No
Tobacco abuse is the primary preventable risk for cardiovascular
disease, which is the leading cause of death in diabetes.
Risk factors for atherosclerosis include: Total Cholesterol <200
LDL>100 HDL<40 in HDL<45 in women TG>200
A baseline EKG should be obtained after diagnosis of diabetes. This
should be repeated every 1-5 years as clinically indicated. For
those 40 years of age and above, or with diabetes duration of over
10 years, an EKG every 1-2 years is recommended.
% of patients
% of patients
Diabetes Treatment
Insulin
Sulfonylurea
Metformin
Acarbose
Troglitazone
Refused or Undetermined
Microalbuminurea present
Microalbuminurea absent
Health Status of Diabetic Patients
0
Who is this report about?
Number of patients with diabetes included in report
0
Is this a random sample or all patients with diabetes?
0
12/31/99
12/31/99
Protein appearing in the urine is an indication of kidney
disease.
% of patients
Proteinurea present
Proteinurea absent
Proteinurea not tested/unknown
Hemoglobin A1c estimates the average degree of glycemic control
over a period of time. Hemoglobin A1c should be monitored at 3-4
month intervals for those with elevated levels (HbA1C
>7.0%).
As a patient's HbA1c gets higher, the risk of complications
increases.
Over time, smoking damages the blood vessels. Coupled with too much
glucose in the blood, the effect can be devastating.
People with type 2 Diabetes who have Microalbuminuria are more
likely to have a heart attack or stroke. Treatment with ACE
Inhibitors slows the deterioration of kidney function in
diabetes.
All patients with LDL >100 require medical nutrition therapy and
lifestyle modifications. Pharmacological intervention is
recommended if dietary interventions and lifestyle modifications
are ineffective in lowering LDL to less than 100. A lipid panel
should be performed annually (TC, LDL, HDL, TG).
Diabetes can be effectively treated and controlled. The duration of
diabetes is related to complications such as kidney disease, cardio
vascular disease and amputation. Intensive treatment can reduce the
risk of complications of diabetes.
&L&D&R&P
<15 years
15-44 years
45-64 years
Type 1
Type 2
BP control undetermined
Age is a risk factor for Type 2 Diabetes. Type 2 Diabetes was
diagnosed predominately in patients age 40 and older. Today, young
adults (30-35) are the fastest growing group of Type 2
Diabetes.
Hemoglobin A1c estimates the average degree of glycemic control
over a period of time. Hemoglobin A1c should be monitored at 3-4
month intervals for those with elevated levels (HbA1C >7.0%). As
a patients HbA1c gets higher, the risk of complications
increases.
% of patients
type of education
% Receiving Educational Sessions
HDL <35 mg/dl
HDL 35-45 mg/dl
HDL 46-55 mg/dl
Not tested
Type 1 Diabetes- Immune-mediated form of diabetes. The body
produces no insulin at all due to islet cell destruction. Type 2
Diabetes-Caused by a combination of insulin resistance and insulin
deficiency. Gestational Diabetes-Diabetes associated with
pregnancy. Impaired Glucose Tolerance (IGT)-Pre-diabetic state
marked by elevated blood sugar. People with IGT are at high risk
for progression to Type 2 diabetes.
Diabetes is not curable, but it can be effectively treated and
controlled. The duration of diabetes is related to complications
such as kidney disease, cardio vascular disease and amputation.
Intensive treatment can reduce the reisk of complications of
diabetes.
Obesity and physical inactivity are associated with the development
of type 2 Diabetes. Adopting habits that control weight and
increasing exercise has been shown to significantly reduce the risk
of developing diabetes. Minimal weight loss of just 10-20 pounds
can improve blood glucose, blood pressure and cholesterol in
patients with type 2 Diabetes.
The target Blood Pressure (BP) for patients with diabetes is <
130/80. High blood pressure increases the risk of heart disease and
renal failure in Type 2 diabetes.
Aspirin is used as a primary and secondary treatment strategy to
prevent cardiovascular events regardless of disease status. Men and
women with diabetes have a 2-4 fold increase in risk of dying from
complications of cardiovascular disease (CVD).
ACE Inhibitors are medication prescribed to patients with diabetes
to prevent kidney damage. Treatment with ACE Inhibitors has been
shown to delay the progression from Microalbuminuria to Proteinuria
in patients with diabetes. It is commonly prescribed to patients
with hypertension as well.
Screening for foot problems, vision problems and dental problems
occur more frequently for patients with diabetes. Persons with
diabetes need their exams at least once a year.
All persons with diabetes should have a flu vaccine and pneumovax
each year. Yearly re-vaccination for flu is recommended to provide
up-to-date protection. The pneumovax vaccine is necessary at least
once and may need a booster according to physician
discretion.
Blood creatinine is a measure of renal function. Patients with
diabetes are at risk for renal disease. This test is to be
performed annually.
% of patients
Total Cholesterol
Unable to determine result
Ever performed
% of patients
Performed in past 3 years
Performed in past 5 years
Ever performed
% of patients
Tuberculosis Status of Patients with Diabetes
Use in pts with overt proteinuria
Use in pts with known hypertension
Self Monitoring Blood Glucose (SMBG) is to determine the pattern of
blood glucose throughout the day. This pattern provides information
for selection and adjustments in therapy.
no. of patients
Yes
No
Refused
Medical nutrition therapy and exercise are the primary treatment
strategies for type 2 Diabetes. All patients with diabetes and
their families should have diabetes self-management education every
year.
% of patients
Tobacco use not documented
% of patients
Tobacco Use
Counseled - Yes
Counseled - No
Tobacco abuse is the primary preventable risk for cardiovascular
disease, which is the leading cause of death in diabetes. Over
time, smoking damages the blood vessels. Coupled with too much
glucose in the blood, the effect can be devastating.
Risk factors for atherosclerosis include: Total Cholesterol <200
LDL>100 HDL<40 in HDL<45 in women TG>200 All patients
with LDL >100 require medical nutrition therapy and lifestyle
modifications. Pharmacologic intervention is recommended if dietary
interventions and lifestyle modifications are ineffective in
lowering LDL to less than 100. A lipid panel should be performed
annually (TC, LDL, HDL, TG).
A baseline EKG should be obtained after diagnosis of diabetes. This
should be repeated every 1-5 years as clinically indicated. For
those 40 years of age and above, or with diabetes duration of over
10 years, an EKG every 1-2 years is recommended.
Patients with diabetes are at risk for activation of latent
tubercoulosis (TB) infection (LBTI). There is a greater risk of
progressing to active Tuberculosis, if not treated. Patients with
diabetes should have a PPD if unknown tuberculosis status.
no. of patients
Insulin
Sulfonylurea
Metformin
Acarbose
Troglitazone
Refused or Undetermined
Proteinurea present
Proteinurea absent
<15 years
15-44 years
45-64 years
65 years and older
Protein appearing in the urine is an indication of kidney disease.
People with type 2 Diabetes who have Microalbuminuria are more
likely to have a heart attack or stroke. Treatment with ACE
Inhibitors slows the deterioration of kidney function in
diabetes.
Patients with diabetes are at risk for activation of latent
tuberculosis (TB) infection (LBTI). There is a greater risk of
progressing to active Tuberculosis, if not treated. Patients with
diabetes should have a PPD if unknown tuberculosis status.
Gender Distribution of Patients with Diabetes Included in
Report
Female
Male
Type 1
Type 2
BP control undetermined
Hemoglobin A1c estimates the average degree of glycemic control
over a period of time. Hemoglobin A1c should be monitored at 3-4
month intervals for those with elevated levels (HbA1C >7.0%). As
a patients HbA1c gets higher, the risk of complications
increases.
% of patients
type of education
% Receiving Educational Sessions
Creatinine >= 2.0mg/dl
Obese (BMI>95%ile)
LDL CHOLESTEROL OBTAINED IN PAST 12 MONTHS
LDL <100 mg/dl
LDL 100-129 mg/dl
LDL 130-160 mg/dl
Not tested
Type 1 Diabetes- Immune-mediated form of diabetes. The body
produces no insulin at all due to islet cell destruction. Type 2
Diabetes-Caused by a combination of insulin resistance and insulin
deficiency. Gestational Diabetes-Diabetes associated with
pregnancy. Pre-diabetes (also called Impaired Glucose Tolerance
(IGT)-Pre-diabetic state marked by elevated blood sugar. People
with Pre-diabetes are at high risk for progression to Type 2
diabetes.
Diabetes is not curable, but it can be effectively treated and
controlled. The duration of diabetes is related to complications
such as kidney disease, cardio vascular disease and amputation.
Intensive treatment and lifestlye interventions can reduce the risk
of complications of diabetes.
Obesity and physical inactivity are associated with the development
of type 2 Diabetes. Adopting habits that control weight and
increasing exercise has been shown to significantly reduce the risk
of developing diabetes. Minimal weight loss of just 10-20 pounds
can improve blood glucose, blood pressure and cholesterol in
patients with type 2 diabetes.
The target Blood Pressure (BP) for patients with diabetes is <
130/85. High blood pressure increases the risk of heart disease and
renal failure in Type 2 diabetes.
Aspirin is used as a primary and secondary treatment strategy to
prevent cardiovascular events regardless of disease status. Men and
women with diabetes have a 2-4 fold increase in risk of dying from
complications of cardiovascular disease (CVD). Unless there are
reasons otherwise , all patients with diabetes should be on aspirin
therapy.
ACE Inhibitors are medication prescribed to patients with diabetes
to prevent kidney damage. Treatment with ACE Inhibitors has been
shown to delay the progression from Microalbuminuria to Proteinuria
in patients with diabetes. It is commonly prescribed to patients
with hypertension as well.
Screening for foot problems, vision problems and dental problems
occur more frequently for patients with diabetes. Persons with
diabetes need their exams at least once a year.
All persons with diabetes should have a flu vaccine and pneumovax
each year. Yearly re-vaccination for flu is recommended to provide
up-to-date protection. The pneumovax vaccine is necessary at least
once and may need a booster according to physician
discretion.
Blood creatinine is a measure of renal function. Patients with
diabetes are at risk for renal disease. This test is to be
performed annually.
% of patients
Desirable (<200 mg/dl)
Borderline (200-239 ,g/dl)
Unable to determine result
HDL <35 mg/dl
HDL 35-45 mg/dl
HDL 46-55 mg/dl
TG <150 mg/dl
TG 150-199 mg/dl
TG 200-400 mg/dl
TG >400 mg/dl
Ever performed
% of patients
PPD +, INH treatment complete
PPD -, placed before DM dx or date unknown
PPD status unknown
Tuberculosis Status of Patients with Diabetes
Use in pts with overt proteinuria
Use in pts with known hypertension
Self Monitoring Blood Glucose (SMBG) is to determine the pattern of
blood glucose throughout the day. This pattern provides information
for selection and adjustments in therapy.
% of patients
Yes
No
Refused
Medical nutrition therapy and exercise are the primary treatment
strategies for type 2 Diabetes. All patients with diabetes and
their families should have diabetes self-management education every
year.
% of patients
Tobacco use not documented
Tobacco Use
Counseled - Yes
Counseled - No
Over time, smoking damages the blood vessels. Coupled with too much
glucose in the blood, the effect can be devastating.
Risk factors for atherosclerosis include: Total Cholesterol <200
LDL>100 HDL<40 in HDL<45 in women TG>200 All patients
with LDL >100 require medical nutrition therapy and lifestyle
modifications. Pharmacological intervention is recommended if
dietary interventions and lifestyle modifications are ineffective
in lowering LDL to less than 100. A lipid panel should be performed
annually (TC, LDL, HDL, TG).
A baseline EKG should be obtained after diagnosis of diabetes. This
should be repeated every 1-5 years as clinically indicated. For
those 40 years of age and above, or with diabetes duration of over
10 years, an EKG every 1-2 years is recommended.
% of patients
% of patients
Diabetes Treatment
Insulin
Sulfonylurea
Metformin
Acarbose
Troglitazone
Refused or Undetermined
Microalbuminurea present
Microalbuminurea absent
Diabetes Data Report - Comparison
12/31/99
12/31/99
12/31/99
12/31/99
Denominator:
0
0
0
0
The following report tracks diabetes over four time periods. By
viewing the diabetes related information over time we can track
improvements in patient care and disease management. As you look at
these graphs think about factors that may be contributing
Who is this report about?
Status of Patients included in report
12/31/99
12/31/99
Protein appearing in the urine is an indication of kidney disease.
People with type 2 Diabetes who have Microalbuminuria are more
likely to have a heart attack or stroke. Treatment with ACE
Inhibitors slows the deterioration of kidney function in
diabetes.
% of patients
Proteinurea present
Proteinurea absent
Proteinurea not tested/unknown
Diabetes is a disease that is disproportionately affecting the
American Indian and Alaskan Native communities. Armed with the
right information we can work together to fight and eventually
prevent this disease. First, we need to know the true facts about
diabetes in each tribe and community. This report is the picture
the numbers paint for us. This information is based on your
clinic’s tracking of diabetes in your community for a one year time
frame. It is based on information tracked in the Resource Patient
Management System (RPMS) or compiled in an annual chart review. By
looking at this information we can best target health resources,
support those in the community with diabetes and prevent diabetes
in future generations. Much of the narrative information found in
this report is taken from the 2001 "Indian Health Service Standards
of Care.
Tobacco abuse is the primary preventable risk for cardiovascular
disease, which is the leading cause of death in diabetes.
Diabetes can be effectively treated and controlled. The duration of
diabetes is related to complications such as kidney disease, cardio
vascular disease and amputation. Intensive treatment can reduce the
risk of complications of diabetes.
&LDRAFT &D&R&P
%
Female
Male
<15 years
15-44 years
45-64 years
Type 1
Type 2
BP control undetermined
Tobacco use not documented
Diet and Exercise Alone or Undocumented
Insulin
Sulfonylurea
Metformin
Acarbose
Troglitazone
Refused or Undetermined
%
%
%
Unable to determine result
TG <150 mg/dl
TG 150-199 mg/dl
TG 200-400 mg/dl
TG >400 mg/dl
Ever performed
PPD -, placed before DM dx or date unknown
PPD status unknown
Less than 10 years
10 years or more
Diagnosis date not recorded
Obese (BMI>95%ile)
Source: Site Name and Year IHS Diabetes Audit
Type 1 Diabetes- Immune-mediated form of diabetes. The body
produces no insulin at all due to islet cell destruction.
Type 2 Diabetes-Caused by a combination of insulin resistance and
insulin deficiency.
Gestational Diabetes-Diabetes associated with pregnancy.
Pre-Diabetes (also called Impaired Glucose Tolerance
(IGT)-Pre-diabetic state marked by elevated blood sugar. People
with IGT are at high risk for progression to Type 2 Diabetes.
Chart7
Health Status of Diabetic Patients
Use this spreadsheet to generate reports to illustrate patient
demographics and care outcomes tracked and reported in the Indian
Health Service Diabetes Audit. This report allows you to enter
information found either on your annual Indian Health Service
Directions:
1.Items in the yellow cells are found in the Diabetes Audit. Refer
to either your annual Indian Health Service Diabetes Audit or
generate the "cumulative audit" in the Diabetes Management
System.
2. Enter corresponding PERCENTAGES (%) into the cells for each time
frame.
3. View and print your custom report by clicking on the tabs
below.
4. Questions? Contact the Western Tribal Diabetes Program at
1-800-862-5497, attention Jen Olson.
Time 1
Time 2
Time 3
Time 4
Is this a random sample or all patients with diabetes?
Data Source
manual chart audit
Obese (BMI>95%ile)
BP control undetermined
Tobacco use not documented
Insulin
Sulfonylurea
Metformin
Acarbose
Troglitazone
Refused or Undetermined
CHRONIC ASPIRIN THERAPY
Use in pts with overt proteinuria
Use in pts with known hypertension
LIPID LOWERING AGENT USE
EXAMS - YEARLY
IMMUNIZATIONS
Proteinurea present
Proteinurea absent
Creatinine >= 2.0mg/dl
Desirable (<200 mg/dl)
Borderline (200-239 ,g/dl)
Unable to determine result
LDL <100 mg/dl
LDL 100-129 mg/dl
LDL 130-160 mg/dl
HDL <35 mg/dl
HDL 35-45 mg/dl
HDL 46-55 mg/dl
TG <150 mg/dl
TG 150-199 mg/dl
TG 200-400 mg/dl
TG >400 mg/dl
Ever performed
TUBERCULOSIS STATUS
PPD -, placed before DM dx or date unknown
PPD status unknown
Yes
No
Refused
*OPTIONS FOR STATUS::
Clinic Definitions of status (please enter your clinic's definition
for each status)
Active
Inactive
Transient
Deceased
Non-HIS
Unreviewed
0
12/31/99
0
Number of patients with diabetes included in report
0
Is this a random sample or all patients with diabetes?
0
12/31/99
&LDate last updated:&D&R&P
Patients with diabetes are at risk for activation of latent
tuberculosis (T